BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10223246)

  • 1. Pleomorphic xanthoastrocytoma: what do we really know about it?
    Giannini C; Scheithauer BW; Burger PC; Brat DJ; Wollan PC; Lach B; O'Neill BP
    Cancer; 1999 May; 85(9):2033-45. PubMed ID: 10223246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.
    Ganly I; Patel SG; Singh B; Kraus DH; Bridger PG; Cantu G; Cheesman A; De Sa G; Donald P; Fliss DM; Gullane P; Janecka I; Kamata SE; Kowalski LP; Levine PA; Medina dos Santos LR; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):73-8. PubMed ID: 16415433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
    McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
    Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis.
    Pahapill PA; Ramsay DA; Del Maestro RF
    Neurosurgery; 1996 Apr; 38(4):822-8; discussion 828-9. PubMed ID: 8692406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.
    Luyken C; Blümcke I; Fimmers R; Urbach H; Wiestler OD; Schramm J
    Cancer; 2004 Jul; 101(1):146-55. PubMed ID: 15222000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary atypical carcinoid: predictors of survival in 106 cases.
    Beasley MB; Thunnissen FB; Brambilla E; Hasleton P; Steele R; Hammar SP; Colby TV; Sheppard M; Shimosato Y; Koss MN; Falk R; Travis WD
    Hum Pathol; 2000 Oct; 31(10):1255-65. PubMed ID: 11070119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
    Marton E; Feletti A; Orvieto E; Longatti P
    J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer.
    Kato T; Kameoka S; Kimura T; Tanaka S; Nishikawa T; Kobayashi M
    Anticancer Res; 2002; 22(2B):1105-12. PubMed ID: 12168908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
    Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
    Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor recurrence and malignant progression of gangliogliomas.
    Majores M; von Lehe M; Fassunke J; Schramm J; Becker AJ; Simon M
    Cancer; 2008 Dec; 113(12):3355-63. PubMed ID: 18988291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic xanthoastrocytoma: DNA flow cytometry and outcome analysis of 12 patients.
    Rostomily RC; Hoyt JW; Berger MS; Kros JM; Alvord EC; Wilkins P; Rabinovitch P
    Cancer; 1997 Dec; 80(11):2141-50. PubMed ID: 9392337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical results of supratentorial astrocytoma grade II].
    Matsumoto K; Abe T; Terada K; Tabuchi A; Adachi Y; Mizumatsu S; Ono Y; Tamiya T; Ohmoto T; Furuta T
    No Shinkei Geka; 1999 Feb; 27(2):139-45. PubMed ID: 10065446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.